雲南白藥(000538.SZ):子公司擬投資設立香港公司
格隆匯 3 月 4日丨雲南白藥(000538.SZ)公佈,為進一步推動雲南白藥集團股份有限公司國際化進程,強化對海外控(參)股公司的管理,建立公司海外資源整合機制,更好地完善公司戰略佈局,公司擬由全資子公司雲南白藥集團(海南)有限公司(“海南公司”)以自有資金1萬港幣在香港投資設立全資公司——雲南白藥(香港)有限公司(“香港公司”)。
公司投資設立香港公司將有助於公司在確保正常運營的前提下,有效整合海外醫藥、醫療及健康產業資源,提升對海外資源的整合能力和利用效率,搭建海外資源整合和利用架構,利用好國內、國外兩個市場,將擬設的香港公司作為國內、國外兩個循環的銜接點,有效提升公司國際化程度,為公司轉型發展和戰略落地提供支撐。
海南公司投資設立香港公司將有助於公司有效利用全球資源服務中國市場,同時,也將為國內優質資源出海提供優質渠道,有利於公司進一步提升自身競爭實力、鞏固行業地位,推動戰略目標的落地,符合公司的發展戰略和股東的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.